Trials / Recruiting
RecruitingNCT07160946
Risk Assessment for HBV-Related Liver Cancer
Research on Risk Assessment and Intervention of HBV-Related Liver Cancer Based on Multimodal Data Fusion
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,000 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | AI folow-up system | In AI follow-up group, patients will be followed up by an AI system. |
Timeline
- Start date
- 2025-05-10
- Primary completion
- 2032-12-30
- Completion
- 2032-12-30
- First posted
- 2025-09-08
- Last updated
- 2025-09-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07160946. Inclusion in this directory is not an endorsement.